AstraZeneca set to showcase the latest science at ERS Congress 2020

We aim to transform the treatment of respiratory disease with our growing portfolio of inhaled and biologic medicines, along with following the science of common pathways and underlying disease drivers from respiratory disease into immunology-driven disease areas. We look forward to virtually joining clinicians, researchers and scientists at the ERS 2020 Congress to share the latest in Respiratory & Immunology science advancements.

Follow us for updates from the Congress, and join the conversation using #ERSCongress.


September 2020

Relegating OCS to last resort: creating a paradigm shift in severe asthma management

SABA status quo: state of emergency from policy to patient

Early prevention: protecting patients from the consequences of COPD exacerbations

Frontiers in eosinophilic diseases

Epithelial cytokines in the airway: recent advances in severe asthma



Advancing the science of Respiratory & Immunology for patients

How can we make the biggest possible difference for patients? Hear from the team at AstraZeneca who are working to advance cutting-edge science and our growing pipeline in Respiratory and Immunology.


Join Our Team



At AstraZeneca Respiratory & Immunology, we’re driven by innovation and our commitment to make a real-life difference in patients’ lives. That difference starts with you.




Veeva ID: Z4-26801
Date of Prep: August 2020
Date of Expiry: August 2022